JA
Jeslet Abel
About Jeslet Abel
Data last updated:
Jeslet Abel is a Director at Regency Lifesciences (India) Private Limited (since 2019) and Designated Partner at Odyssey Therapeia Llp (since 2020). The companies operate in Healthcare. The largest current company by reported revenue is Regency Lifesciences (India) Private Limited at ₹11.22 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Regency Lifesciences (India) Private Limited U24231KA2009PTC051931 | Director | 28 Jun 2019 | 2009 | ₹11.22 Cr (FY 2025) | Active |
| Odyssey Therapeia Llp AAT-3621 | Designated Partner | 14 Aug 2020 | 2020 | Active |
Board colleagues of Jeslet Abel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abel Boodala Alexander | 02697631 | Regency Lifesciences (India) Private Limited , Odyssey Therapeia Llp | Managing Director |
| Boodala Abraham Abel | 08834731 | Odyssey Therapeia Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jeslet Abel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jeslet Abel
Jeslet Abel currently holds 2 directorships: Regency Lifesciences (India) Private Limited (Director, since 28 Jun 2019, revenue ₹11.22 Cr (FY 2025)); Odyssey Therapeia Llp (Designated Partner, since 14 Aug 2020).
Jeslet Abel was first appointed on 28 Jun 2019 as Director at Regency Lifesciences (India) Private Limited. The most recent appointment on record is 14 Aug 2020 at Odyssey Therapeia Llp.
The current boards of Jeslet Abel's companies include Abel Boodala Alexander (Regency Lifesciences (India) Private Limited), Boodala Abraham Abel (Odyssey Therapeia Llp).